Treatment for acute renal failure in children

Author info »

Description

Among children who are critically unwell, Acute Kidney Damage (AKI) affects a sizable percentage of them. According to a recent study that used a modified definition of AKI, up to 10% of all kids hospitalised to the Paediatric Intensive Care Unit (PICU) have some sort of kidney damage. The regulation of vascular tone, acid-base balance, erythropoiesis, and fluid balance are just a few of the many homeostatic processes that the kidney plays a key role in. Therefore, abnormalities in renal function may have a detrimental effect on host survival. AKI is frequently acknowledged as a multiorgan illness consequence that independently raises the risk of mortality [1-6].

RRT is used for AKI, fluid overload, and sepsis despite the lack of official and explicit indications for use. While updated definitions of AKI have helped to stratify injury severity, the use of RRT is controversial and ambiguous. It is unknown which patients are suitable for therapy, which modalities should be employed, what the initiation triggers are, what “dosage” should be recommended, and how long treatment should last.

The most extensively utilised type of renal replacement therapy for children is Peritoneal Dialysis (PD). Almost all facilities that provide care for sick children may put this strategy into action. PD is crucial for developing nations with few resources in particular. Due to its low cost and simplicity of usage, PD is the most popular kind of RRT in both adults and children globally. PD is highly efficient at removing solute and fluid in trained hands and may be customised to patient demands. If vascular catheter placement is challenging, medical professionals should be aware of the risk for PD. This treatment option is best for newborns, kids with poor vascular access, and kids who can handle delayed fluid drainage and electrolyte correction because it doesn’t call for anticoagulation.

The treatment for acute ingestions, poisons, and fluid overload is intermittent hemodialysis. Ischemic Heart Disease (IHD) entails hazards for line installation, technical challenges with small patients and newborns, and consequences from rapid changes in fluids and electrolytes. The patients who would benefit from and be able to endure high doses of dialysis in a short period of time and those with acute electrolyte imbalances should choose IHD.

Some of these questions are attempted to be answered by retrospective data. The use of Continuous Renal Replacement Therapy (CRRT) is expanding along with the development of center-specific technical competence. The capacity to precisely control fluid balance and electrolyte imbalances makes CRRT an excellent choice in the hemodynamically unstable patient, despite the lack of evidence supporting its superiority over PD or IHD. Additionally, it would be ideal to be able to provide blood products and medications while receiving CRRT (without having to worry too much about fluid shifts).

The key factor driving the growth in the usage of CRRT is the strict management of such deliverables, which is essential in the treatment of critically ill paediatric patients. Institutional capacity, technical comfort, and the ability to gain sufficient vascular access are obstacles to its usage, although this modality’s efficacy in unstable patients is an appealing feature. To assess morbidity and mortality between the three dialytic modalities, there are few prospective data available. In a study comparing PD and CRRT for adults with infection-related AKI, it was discovered that CRRT considerably outperformed PD in all of the evaluated endpoints (reduction of creatinine, resolution of acidosis). The data on children is generally few, retrospective, and frequently restricted to particular illness processes, like cardiopulmonary bypass.

Kidney replacement therapy is increasingly being used in paediatrics. It is unclear if the apparent benefits of dialysis outweigh the hazards, both mechanical and technical (improved renal recovery or reduced mortality). Currently, the only ethically sound approach to address the matter would be to undertake a prospective, randomised trial contrasting the various RRT modalities versus no invasive therapy. Furthermore, it is unknown when to intervene, if acute dialysis for AKI is in fact advantageous.

Kidney replacement therapy is increasingly being used in paediatrics. It is unclear if the apparent benefits of dialysis outweigh the hazards, both mechanical and technical (improved renal recovery or reduced mortality). Currently, the only ethically sound approach to address the matter would be to undertake a prospective, randomised trial contrasting the various RRT modalities versus no invasive therapy. Furthermore, it is unknown when to intervene, if acute dialysis for AKI is in fact advantageous.

With the development of troponins tests, cardiac catheterization and coronary intervention therapy for myocardial infarction were improved when performed on individuals with risk factors and symptoms of disease. Unfortunately, unlike chest discomfort, AKI does not ache, and its signs might be difficult to detect in the absence of fluid overload. AKI’s early phenotype is unknown, which restricts the use of biomarkers, diagnostic methods, and therapeutic approaches. It may be possible to select people most likely to benefit from early renal replacement therapy, improve the usefulness of biomarkers, and strengthen early AKI diagnosis with the discovery of the renal angina equivalent to angina for chest pain and myocardial infarction.

Conclusion

Patients who are most at risk may be identified by renal angina, which is a combination of risk factors (such as high blood pressure, smoking for heart disease and shock, or sepsis for AKI) and modest abnormalities in renal function (such as fluid overload or tiny changes in creatinine clearance). To improve treatment delivery, prospective trials comparing patient cohorts and various RRT modalities are required. The ppCRRT registry intends to accomplish this.

References

1. Schneider J, Khemani R, Grushkin C, et al. Serum creatinine as stratified in the RIFLE score for acute kidney injury is associated with mortality and length of stay for children in the pediatric intensive care unit. Critical care medicine. 2010; 38(3):933-939.

   [Crossref][Google scholar][Pubmed]

2. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. 2005; 294(7):813-818.

   [Crossref][Google scholar][Pubmed]

3. Elapavaluru S, Kellum JA. Why do patients die of acute kidney injury? Acta clinica Belgica. 2007; 62:326-31.

   [Crossref][Google scholar][Pubmed]

4. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure–definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical care. 2004; 8(4):1-9.

   [Crossref][Google scholar][Pubmed]

5. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Critical care. 2007; 11(2):1-8.

   [Crossref][Google scholar][Pubmed]

6. Akcan-Arikan A, Zappitelli M, Loftis LL, et al. Modified RIFLE criteria in critically ill children with acute kidney injury. KI. 2007; 71(10):1028-35.

   [Crossref][Google scholar][Pubmed]